DR Congo to receive 70,000 doses of Ervebo vaccine as Ebola infections surge
The Democratic Republic of Congo (DRC) will receive 70,000 doses of the Ervebo Ebola vaccine to combat its largest outbreak, which has resulted in nearly 2,500 deaths. The World Health Organization (WHO) announced the allocation from the global vaccine stockpile.

Briefing Summary
AI-generatedThe Democratic Republic of Congo (DRC) will receive 70,000 doses of the Ervebo Ebola vaccine to combat its largest outbreak, which has resulted in nearly 2,500 deaths. The World Health Organization (WHO) announced the allocation from the global vaccine stockpile. Of the total doses, 20,000 will be used in a late-stage trial to assess the vaccine's effectiveness against the Bundibugyo virus, responsible for the current outbreak, as Ervebo is not yet licensed for this specific strain. The remaining 50,000 doses are designated for frontline and health workers. Gavi will fund the shipment and vaccination efforts.
Article analysis
Model · rule-basedKey claims
5 extractedGavi will provide $7m for vaccine shipment and $6m for vaccination efforts.
Ervebo vaccine is licensed for Ebola virus but not for Bundibugyo virus.
The Bundibugyo virus has killed 2,476 people out of 5,208 confirmed cases.
DRC will receive 70,000 doses of the Ervebo vaccine to combat the Ebola virus.
The current Ebola outbreak in DRC is caused by the Bundibugyo virus.